Skip to main content
. 2023 Mar 28;9(4):763–776. doi: 10.1021/acscentsci.2c01465

Figure 10.

Figure 10

In vivo anticancer efficacy. (a) Designs for mouse anticancer efficacy assays: murine breast cancer (4T1) implanted orthotopically in the mammary fat pad of immunocompetent Balb/c mice and human pancreatic cancer (BxPC-3) implanted subcutaneously in athymic nu/nu NMRI mice. (b, c) Tumor volume (TV) over the course of the studies (median values). (d, e) TV at study termination (raw values with means; days 21 and 62, respectively; p-values from Kruskal–Wallis test indicated where p < 0.05). See also Figure S17.